Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine vs Sildenafil in Idiopathic Oligohydramnios
NCT07135037Phase 2Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine, ASP-001 in Oligohydramnios (Oligo), sponsored by Kafrelsheikh University. Started Sep 2024; status: recruiting.
02
Drugs
arginineASP-001
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT07135037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07135037.